Medication Doses and Frequencies for H. pylori Treatment
The standard recommended regimens for H. pylori treatment include bismuth quadruple therapy for 14 days as first-line treatment (bismuth ~300mg qid, metronidazole 500mg tid, tetracycline 500mg qid, PPI bid), with clarithromycin triple therapy and levofloxacin-based regimens as alternatives based on local resistance patterns. 1
First-Line Treatment Options
Bismuth Quadruple Therapy (14 days)
- Bismuth subsalicylate: 300mg (2 tablets/capsules) four times daily, 30 minutes before meals
- Tetracycline HCl: 500mg four times daily, 30 minutes after meals
- Metronidazole: 500mg three times daily
- PPI: Standard dose twice daily, 30 minutes before meals
- Standard PPI doses: pantoprazole 40mg, lansoprazole 30mg, omeprazole 20mg, esomeprazole 20mg, dexlansoprazole 30mg, rabeprazole 20mg 1
Clarithromycin Triple Therapy (14 days)
Note: Only use in regions with low clarithromycin resistance (<15%) 1
Concomitant Non-Bismuth Quadruple Therapy (14 days)
- Clarithromycin: 500mg twice daily
- Amoxicillin: 1g twice daily
- Metronidazole/tinidazole: 500mg twice daily
- PPI: Standard dose twice daily 1
Second-Line Treatment Options
Levofloxacin Triple Therapy (14 days)
- Levofloxacin: 500mg once daily in the morning
- Amoxicillin: 1g twice daily
- PPI: Standard dose twice daily 1
Note: FDA recommends fluoroquinolones be used as a last choice due to risk of serious side effects 1
Rifabutin Triple Therapy (10-14 days)
- Rifabutin: 150mg twice daily or 300mg once daily
- Amoxicillin: 1g twice daily
- PPI: Standard dose twice daily 1
High-Dose Dual Therapy (14 days)
- Amoxicillin: 2-3g daily in 3-4 split doses
- PPI: High-dose (double standard dose) twice daily 1
PPI Administration Guidelines
- Optimal PPI dosing: 30 minutes prior to eating on an empty stomach
- Avoid concomitant use of other antacids (e.g., H2 receptor antagonists)
- Higher-potency PPIs recommended: 20-40mg esomeprazole or rabeprazole twice daily 1
- Standard PPI doses: pantoprazole 40mg, lansoprazole 30mg, omeprazole 20mg, esomeprazole 20mg, dexlansoprazole 30mg, rabeprazole 20mg 1
Treatment Selection Algorithm
First-line therapy selection:
- In regions with high clarithromycin resistance (>15%): Bismuth quadruple therapy
- In regions with low clarithromycin resistance (<15%): Clarithromycin triple therapy
After first-line failure:
- If clarithromycin-based therapy failed: Use bismuth quadruple therapy
- If bismuth quadruple therapy failed: Use levofloxacin-based therapy
After two failed therapies:
Important Clinical Considerations
- Treatment duration of 14 days is recommended for all regimens to improve eradication success 1, 3
- After treatment completion, wait at least 4 weeks before testing for H. pylori eradication 3
- Adjunctive therapies like probiotics are of unproven benefit and should be considered experimental 1
- For H. pylori dosing in dual therapy: 1g amoxicillin and 30mg lansoprazole, all given three times daily for 14 days 2
Common Pitfalls to Avoid
- Using shorter treatment durations (7-10 days) which reduce eradication rates
- Failing to account for local antibiotic resistance patterns
- Not considering patient's prior antibiotic exposure history
- Using outdated regimens like sequential or hybrid therapies that are now considered obsolete 1
- Inadequate PPI dosing or timing (should be taken 30 minutes before meals) 1
- Not waiting sufficient time (4 weeks) after treatment completion before testing for eradication 3